Work

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

Year: 1994

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1038/clpt.1994.184

Authors: Anu Varhe, Klaus T Olkkola, Pertti J Neuvonen

Institution: University of Helsinki

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2004576165

FWCI: 11.4

Cites:

Cited by: 277

Related to: 10